Wolverine Asset Management’s Emergent Biosolutions EBS Stock Holding History

Wolverine Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.47M	Hold	174,933	–	–	0.01%	693
2026 Q1	$1.45M	Hold	174,933	–	–	0.01%	674
2025 Q4	$2.16M	Hold	174,933	–	–	0.02%	585
2025 Q3	$1.54M	Hold	174,933	–	–	0.01%	629
2025 Q2	$1.12M	Buy	174,933 +38,600	+28%	+$221K	0.01%	679
2025 Q1	$663K	Hold	136,333	–	–	0.01%	792
2024 Q4	$1.3M	Buy	+136,333	New	+$1.25M	0.01%	624
2021 Q4	–	Sell	-2,695	Closed	-$134K	–	2090
2021 Q3	$134K	Hold	2,695	–	–	﹤0.01%	1238
2021 Q2	$169K	Sell	2,695 -3,856	-59%	-$248K	﹤0.01%	1311
2021 Q1	$608K	Buy	+6,551	New	+$671K	0.01%	836
2018 Q4	–	Sell	-1,498	Closed	-$98K	–	1637
2018 Q3	$98K	Hold	1,498	–	–	﹤0.01%	1284
2018 Q2	$75K	Hold	1,498	–	–	﹤0.01%	1208
2018 Q1	$78K	Hold	1,498	–	–	﹤0.01%	1248
2017 Q4	$69K	Buy	+1,498	New	+$63.1K	﹤0.01%	1217

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Wolverine Asset Management's EBS Position: Q2 2026 in Review

Wolverine Asset Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 174,933 shares worth $1.47M. The position accounts for 0.01% of the portfolio, ranked #693.

Wolverine Asset Management first reported a position in EBS in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.16M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Wolverine Asset Management held 174,933 shares of Emergent Biosolutions worth $1.47M as of Q2 2026.
Wolverine Asset Management left its Emergent Biosolutions share count unchanged in Q2 2026.
Emergent Biosolutions made up 0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #693 holding.
Wolverine Asset Management first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 14 quarters since.
Wolverine Asset Management's Emergent Biosolutions position peaked at $2.16M in Q4 2025.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.